Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Talpaz

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
Medgenmed : Medscape General Medicine|June 21, 2003
Treatment of CML: thoughts after ASCO 2002Moshe Talpaz
Clinical Lymphoma & Myeloma|March 4, 2009
The fine tuning of therapy for chronic myeloid leukemia and upcoming challengesMoshe Talpaz
Nature Reviews. Cancer|April 4, 2008
Getting to the stem of chronic myeloid leukaemiaMichael Savona, Moshe Talpaz
Clinical Lymphoma, Myeloma & Leukemia|August 27, 2017
New Series: SOHO 'State of the Art Updates and Next Questions'Hagop Kantarjian, Moshe Talpaz
Oncology (Williston Park, N.Y.)|July 18, 2006
Chronic myeloid leukemia: changing the treatment paradigmsMichael Savona, Moshe Talpaz
Blood Reviews|October 11, 2011
Managing resistance in chronic myeloid leukemiaSameek Roychowdhury, Moshe Talpaz
Hematology. American Society of Hematology. Education Program|December 17, 2009
Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistanceDale Bixby, Moshe Talpaz
Leukemia & Lymphoma|December 11, 2007
Strategies for overcoming imatinib resistance in chronic myeloid leukemiaLisa Kujawski, Moshe Talpaz
Hematology (Amsterdam, Netherlands)|October 17, 2013
Hematology clinic: chronic myelogenous leukemiaAlissa A Weber, Moshe Talpaz
Leukemia|July 11, 2020
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosisMoshe Talpaz, Jean-Jacques Kiladjian
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
Medgenmed : Medscape General Medicine|June 21, 2003
Treatment of CML: thoughts after ASCO 2002Moshe Talpaz
Clinical Lymphoma & Myeloma|March 4, 2009
The fine tuning of therapy for chronic myeloid leukemia and upcoming challengesMoshe Talpaz
Nature Reviews. Cancer|April 4, 2008
Getting to the stem of chronic myeloid leukaemiaMichael Savona, Moshe Talpaz
Clinical Lymphoma, Myeloma & Leukemia|August 27, 2017
New Series: SOHO 'State of the Art Updates and Next Questions'Hagop Kantarjian, Moshe Talpaz
Oncology (Williston Park, N.Y.)|July 18, 2006
Chronic myeloid leukemia: changing the treatment paradigmsMichael Savona, Moshe Talpaz
Blood Reviews|October 11, 2011
Managing resistance in chronic myeloid leukemiaSameek Roychowdhury, Moshe Talpaz
Hematology. American Society of Hematology. Education Program|December 17, 2009
Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistanceDale Bixby, Moshe Talpaz
Leukemia & Lymphoma|December 11, 2007
Strategies for overcoming imatinib resistance in chronic myeloid leukemiaLisa Kujawski, Moshe Talpaz
Hematology (Amsterdam, Netherlands)|October 17, 2013
Hematology clinic: chronic myelogenous leukemiaAlissa A Weber, Moshe Talpaz
Leukemia|July 11, 2020
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosisMoshe Talpaz, Jean-Jacques Kiladjian
Pageof 27